Sandra Guilmeau

Sandra Guilmeau

Auto-generated profile, based on publicly available information

Sandra Guilmeau

Université Paris Cité, Centre National de la Recherche Scientifique, INSERM, Institut Cochin, Paris, France

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Cell Metabolism
Verified
Journal Article
Closed access
AAAya Abdul-Wahed
Aya Abdul-Wahed
SGSandra Guilmeau
Sandra Guilmeau
CPCatherine Postic
Catherine Postic

1 May 2013 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
GFGaëlle Filhoulaud
Gaëlle Filhoulaud
SGSandra Guilmeau
Sandra Guilmeau
RDRenaud Dentin
Renaud Dentin
JGJean Girard
Jean Girard
CPCatherine Postic
Catherine Postic

1 July 2001 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
MBMarion Buyse
Marion Buyse
MOMarie‐Louise Ovesjö
Marie‐Louise Ovesjö
HGHélène Goïot
Hélène Goïot
SGSandra Guilmeau
Sandra Guilmeau
GPGabriel Péranzi
Gabriel Péranzi
ABAndré Bado
André Bado

1 April 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
PRPatricia Rouet-Benzineb
Patricia Rouet-Benzineb
TAThomas Aparicio
Thomas Aparicio
SGSandra Guilmeau
Sandra Guilmeau
CPCécile Pouzet
Cécile Pouzet
VDVéronique Descatoire
Véronique Descatoire
ABAndré Bado
André Bado
This study shows that leptin induced a rapid phosphorylation of p42/44 mitogen-activated protein kinase, an enhancement of both NF-κB DNA binding and transcriptional activities, and a concentration-dependent increase of HT-29 cell proliferation. These effects are consistent with the presence of leptin receptors on cell membranes. The leptin induction of cell growth was associated with an increase of cell population in S and G2/M phase compared with control cells found in G0/G1 phase of the cell cycle. Moreover, cyclin D1 immunoreactivity was enhanced in leptin-treated HT-29 cells and this increase was essentially associated with cell population in G0/G1 phase. On the other hand, we observed that sodium butyrate inhibited cell proliferation by blocking HT-29 cells in G0/G1 phase of the cell cycle. Interestingly, at physiological concentration, leptin prevented sodium butyrate-induced morphological nucleus changes, DNA laddering and suppressed butyrate-induced cell cycle arrest. This anti-apoptotic effect of leptin was associated with HT-29 cell proliferation and activation NF-κB pathways. However, the phosphorylation of p42/44 MAP kinase in response to leptin was reduced in butyrate-treated cells. These data demonstrated that leptin is a potent mitogenic factor for intestinal epithelial cells through the MAP kinase and NF-κB pathways. They also showed, for the first time, that leptin promotes colon cancer HT-29 cell survival upon butyrate challenge by counteracting the apoptotic programs initiated by this short chain fatty acid probably through the NF-κB pathways. Although further studies are required to unravel the precise mechanism, these data may have significance in the pathogenesis of colorectal cancer and ulcerative colitis diseases.

1 December 2008 in Experimental Cell Research
Verified
Journal Article
Closed access
MFMarta Flandez
Marta Flandez
SGS. Guilmeau
S. Guilmeau
PBP. Blache
P. Blache
LAL.H. Augenlicht
L.H. Augenlicht

1 February 2005 in Diabetes
Verified
Journal Article
Closed access
PDF file
RDRobert Ducroc
Robert Ducroc
SGSandra Guilmeau
Sandra Guilmeau
KAKhalil Akasbi
Khalil Akasbi
HDHélÈnE Devaud
HélÈnE Devaud
MBMarion Buyse
Marion Buyse
ABAndré Bado
André Bado
The effect of leptin on glucose transport was studied in rat jejunal mucosa in Ussing chambers. Leptin was added in the luminal or the serosal compartment before the tissues were challenged with 1, 10, or 50 mmol/l glucose. In response to 10 mmol/l glucose, the increase in short-circuit current (ΔIsc) reached 26.8 ± 2.1 μA/cm2. Luminal addition of leptin dramatically decreased glucose-induced Isc (90.5% for 10 nmol/l leptin). Inhibition was maximal after 5 min and dose dependent (IC50 = 0.13 nM). Western blot analysis showed that rapid inhibition of glucose-induced Isc by leptin was associated with a parallel decrease in the abundance of sodium-glucose transporter-1 in brush border membranes. Inhibition by luminal leptin of ΔIsc was prevented by inhibitor of conventional protein kinase C isoforms. Serosal addition of leptin did not decrease glucose-induced Isc within 5 min and reached maximum after 10 min. The effect of leptin from serosal side was blocked by cholecystokinin (CCK) receptor-2 receptor antagonist YM022. Altogether, these data demonstrate that luminal leptin induces rapid inhibition of glucose entry into enterocyte. The slower action of leptin on the serosal side of mucosa seems indirect and is likely mediated by endogenous CCK. They demonstrate that gut leptin is a major regulator of rapid intestinal glucose transport.